Target identification of situations of improvement through medication review in patients type 2 diabetes
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: CARAMONA, Margarida (Faculty of Pharmacy, Coimbra University, Pharmacology and Pharmaceutical Care, Coimbra, Portugal)
- Co-author(s): Simões, A.L. (Pharmacology and Pharmaceutical Care, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal)
Castel-Branco, M.M. (1Pharmacology and Pharmaceutical Care, Faculty of Pharmacy, University of Coimbr, Coimbra, Portugal)
Fernandez-Llimós, F. (Department of Social Pharmacy, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal)
Figueiredo, I.V. (Center for Pharmaceutical Studies, University of Coimbra, Coimbra, Portugal)
Prevention, early detection and management of diabetes are fundamental for stopping this present epidemic. Medication review may contribute to the early detection of negative clinical outcomes risk factors associated to the use of medicines.
To use the medication review to identify the situations that may lead to clinical negative .. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.